ArticleFrontiers in pediatrics2026
Analysis of key obstacles affecting long-term inhalation therapy compliance in children with bronchial asthma at primary hospitals.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bronchial asthma is a prevalent chronic respiratory disease in children, with long-term inhalation therapy being essential for disease control; however, adherence remains a significant challenge, particularly in primary care settings. This study aimed to identify the key obstacles affecting long-term inhalation therapy compliance among pediatric asthma patients managed at primary hospitals. Methods: A retrospective analysis was conducted on 268 children aged 4-16 years with bronchial asthma who were treated between January 2024 and January 2025. Patients were divided into poor adherence [Morisky Medication Adherence Scale-8 (MMAS-8) score <6] and good adherence (MMAS-8 score 6-8) groups. Data on demographic characteristics, disease-related features, asthma control level, pulmonary function indices, and health-related quality of life (HRQoL) were collected and compared between the two groups. Results: Among the 268 children, 162 (60.4%) were in the poor adherence group and 106 (39.6%) in the good adherence group. The poor adherence group had a lower mean age (7.83 ± 1.72 vs. 8.47 ± 1.68 years), higher proportion of lower household income (10.49% vs. 4.72% with income <10,000 yuan), more frequent exacerbations in the past year (4.12 ± 1.24 vs. 2.53 ± 1.07), worse asthma control (30.25% vs. 10.38% uncontrolled), lower forced expiratory volume in 1 s (FEV₁: 75.34 ± 7.12% vs. 82.45 ± 6.34%), and lower total HRQoL score (69.36 ± 5.23 vs. 73.69 ± 5.12) (all Conclusion: Key modifiable barriers to inhalation therapy adherence in children with asthma at primary hospitals include frequent exacerbations, poor disease control, prior hospitalizations, and household smoking, highlighting the need for multifaceted interventions targeting these factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.